Blood samples were collected via venipuncture into tubes containing K3-EDTA as anticoagulant at the same hospital. Inclusion criteria involve women diagnosed with stage I, II, or III breast cancer via core needle biopsy, regardless of histological type. 28 individuals were eligible to participate ...
We utilized a cohort of women aged 40–85 years who underwent mammography screening (Selenia or Selenia Dimensions; Hologic Inc, Marlborough, MA, USA) at the Hospital of the University of Pennsylvania from 1 September 2010 through 31 December 2014 and did not have a known BRCA1/2 mutation (...